Influenza News and Research

Latest Influenza News and Research

Parents who decline flu vaccination for their child may be exposed to limited information

Parents who decline to get their child vaccinated against the flu may be exposed to a limited range of information, a new national poll suggests.

19 Nov 2018

In-hospital mortality higher among patients with drug-resistant infections

In one of the largest studies to measure the burden of antibiotic resistance in a low- or middle-income country, researchers at the Center for Disease Dynamics, Economics & Policy report that in-hospital mortality is significantly higher among patients infected with multi-drug resistant or extensively drug resistant pathogens including Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii.

17 Nov 2018

InDevR's new VaxArray to improve potency testing for measles and rubella vaccines

InDevR announced today that it will pursue proof of concept development for new VaxArray potency assays for measles and rubella vaccines sponsored by the Bill & Melinda Gates Foundation.

8 Nov 2018

Persuading more health workers to have flu jab needs new approach

Persuading more health workers across the continent to have the flu jab to protect themselves and their patients cannot be done through facts and statistics alone, new research by a leading behavioral scientist from Kingston University in London has revealed.

7 Nov 2018

ECDC study estimates burden of infections caused by antibiotic-resistant bacteria

An ECDC study estimates the burden of five types of infections caused by antibiotic-resistant bacteria of public health concern in the European Union and in the European Economic Area.

6 Nov 2018

Molecular virologist uses basic science to fight influenza

Molecular virologist Chad Petit, Ph.D., uses basic science to fight influenza -- through experiments at the atomic level.

3 Nov 2018

Phase 2 study of ziresovir for treating hospitalized RSV infected infants achieves significant progress

Ark Biosciences, a biotech company developing proprietary therapeutics for viral infection and respiratory diseases, announced today the significant progress in its phase 2 proof-of-concept study of ziresovir in the treatment of hospitalized RSV infected infants.

1 Nov 2018

New study to evaluate human immune system's response to influenza

The key to lasting protection against influenza may be in your bones. The cells that naturally protect you against illness originate and live in your bone marrow - and that is one spot where scientists will be looking to understand the human immune system's response to influenza in a groundbreaking new study led by the Human Vaccines Project.

1 Nov 2018

Scientists discover cell adhesion mechanism used by mycoplasma genitalium

Researchers from the Molecular Biology Institute of Barcelona and the Institute of Biotechnology and Biomedicine have discovered the mechanism by which the bacterium Mycoplasma genitalium) adheres to human cells.

29 Oct 2018

Influenza virus can evolve resistance to experimental antiviral drug

The influenza virus can evolve resistance to an anti-flu drug currently in development for use in pandemics but only if there are multiple genetic mutations, a study has found.

25 Oct 2018

Battling against resistant and sensitive types of influenza A

Another flu season is here, which means another chance for viruses to mutate. Already, most influenza A viruses contain a mutation that confers resistance against one class of antiviral medications, and the bugs are steadily gaining resistance against another class.

25 Oct 2018

FDA approves new antiviral flu treatment

Today, the U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for no more than 48 hours.

24 Oct 2018

High-dose influenza vaccine associated fewer hospitalizations in dialysis patients

Results from a new study suggest that high-dose influenza vaccine is associated with lower risk for hospitalizations in kidney failure patients on dialysis. The findings appear in an upcoming issue of the Clinical Journal of the American Society of Nephrology

24 Oct 2018

Emergex completes toxicology testing on gold nanoparticle carrier system for vaccine platform

Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to synthetic vaccine development in the field of infectious diseases, today announces the successful completion of preclinical toxicology testing on the gold nanoparticle carrier system that forms the fundamental basis for Emergex's entire infectious disease vaccine platform.

24 Oct 2018

Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

Novartis announced today that the full data from the LIBERTY study of Aimovig (erenumab) in episodic migraine patients who had tried and failed two to four prior preventive treatments have been published in the Lancet.

23 Oct 2018

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Takeda Pharmaceutical Company Limited today announced results from the phase 3 VISIBLE 1 clinical trial evaluating the efficacy and safety of an investigational subcutaneous formulation of the gut-selective biologic vedolizumab for maintenance therapy in adult patients with moderately to severely active ulcerative colitis who achieved clinical response* at week 6 following two doses of open-label vedolizumab intravenous induction therapy.

22 Oct 2018

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., today announced detailed results from the Phase III SOLO-1 trial testing LYNPARZA (olaparib) 300 mg tablets twice-daily as a maintenance treatment for patients with newly diagnosed advanced BRCA-mutated ovarian cancer who were in complete or partial response following 1st-line standard platinum-based chemotherapy.

22 Oct 2018

Influenza News and Research

Latest Influenza News and Research

Parents who decline flu vaccination for their child may be exposed to limited information

In-hospital mortality higher among patients with drug-resistant infections

InDevR's new VaxArray to improve potency testing for measles and rubella vaccines

Persuading more health workers to have flu jab needs new approach

ECDC study estimates burden of infections caused by antibiotic-resistant bacteria

Molecular virologist uses basic science to fight influenza

Phase 2 study of ziresovir for treating hospitalized RSV infected infants achieves significant progress

New study to evaluate human immune system's response to influenza

Scientists discover cell adhesion mechanism used by mycoplasma genitalium

Influenza virus can evolve resistance to experimental antiviral drug

Battling against resistant and sensitive types of influenza A

FDA approves new antiviral flu treatment

High-dose influenza vaccine associated fewer hospitalizations in dialysis patients

Emergex completes toxicology testing on gold nanoparticle carrier system for vaccine platform

Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

UT Southwestern biochemist receives 2019 Breakthrough Prize in Life Sciences for innate immunity discovery

New DNA vaccine strategy protects mice against lethal challenge by multiple H3N2 viruses

Researchers develop new techniques for faster detection of Lyme disease bacteria

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Influenza News and Research

Latest Influenza News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in